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Case Report
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Transient global amnesia (TGA) is a clinical syndrome of reversible anterograde amnesia that occurs in the middle-aged and
elderly individuals. The etiology is obscure, and many underlying factors have been reported. We describe an 83-year-old
man with postherpetic neuralgia (PHN) for which he received pregabalin, fentanyl, and a serotonin-norepinephrine reuptake
inhibitor (SNRI). Pain intensity on a numeral rating scale (NRS) was 8/10. He had no history of vascular disease or epilepsy.
On November 28th 20XX he visited our hospital and underwent intercostal nerve block with phototherapy as usual. He was
slightly feverish and had a body temperature of 37.8°C with no other symptoms. After 15 minutes rest, he left our hospital
and tried to return to his home, but he was unsure which train to take. About 4 hours later, he suddenly knew where he was
and got back to his home uneventfully. He had been amnetic for several hours. Two weeks later, he was referred to a neurolo-
gist, and the episode was diagnosed as TGA. Brain magnetic resonance imaging (MRI) showed non-specific cerebral atrophy
with signs of aging at that point. Differential diagnoses include ischemia, migraine, epileptic seizures, and thromboembolic
cerebrovascular disease. The cause of TGA remains controversial. However, drugs such as GABAergic drugs, SNRIs, and
opioids are known to have effects on cognitive function. Polypharmacy can result in substantial drug-drug interactions, espe-
cially in elderly patients. The trigger of this episode in our patient is unclear, but multiple analgesics might have been a causal
factor of his symptoms of TGA.
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Introduction
Transient global amnesia (TGA) is a clinical syndrome
that was proposed by Hodges and Warlow in 1990１）.TGA
is characterized by the sudden onset of anterograde am-
nesia lasting up to 24 hours without compromise of other
neurologic functions in middle-aged and elderly indi-
viduals. We report a case of TGA associated with
postherpetic neuralgia (PHN).
Case Presentation
An 83-year-old man was given a diagnosis of herpes
zoster in the Th8-9 region in June 20XX. He was referred
to our hospital to receive pain management in August
20XX. He complained of continuous and shooting pain
(intensity 7 of 10 on a numerical rating scale[NRS]) in
his chest and back, associated with allodynia. He had no
history of vascular or cerebral diseases, epilepsy, diabetes
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Fig.　1　Magnetic resonance imaging (MRI) of the patient.
Axial diffusion-weighted imaging (DWI) taken 2 weeks after epi-
sode revealed only slight ischemic change.
mellitus, myocardial infarction,mental diseases, or recent
head injury. He also had no histry of temporary memory
loss. No other medication was administered by another
medical department. After thoracic epidural brocks and
intercostal nerve brocks were performed 10 times, the
pain score decreased to 3 of 10 on the NRS. We gave the
patient pregabalin 300 mg/day, celecoxib 200 mg/day,
and vitamine B12 1,500 μg/day.
In November, we changed the prescription to amitrip-
tyline 20 mg/day and pregabaline 300 mg/day because he
claimed to have compressive pain. In October 20XX＋1
he had increasing pain (NRS7/10) associated with the de-
creasing atmospheric temperature in the winter season.
We replaced amitriptyline with duloxetine 20 mg/day,
and decreased the dose of pregabaline to 225 mg/day be-
cause he was staggering. On October 20XX＋2, the pa-
tient claimed to have increasing pain (NRS7/10) in the
winter season again, and we therefore prescribed an
opioid analgesic (fentanyl patch 1 mg/day), pregabaline
150 mg/day, and duloxetine 20 mg/day. No side effect
developed. In July 20XX＋3, fentanyl patch 2 mg/day,
pregabaline 125 mg/day, and duloxetine10 mg/day de-
creased the pain intensity to NRS2/10, but he had mild
sleepiness. In October the pain increased to NRS8/10
again. On November 28th he visited our hospital and re-
ceived intercostal nerve block with 0.5 % bupivacaine 5
ml with phototherapy as usual. Before the treatment he
was slightly feverish (37.8°C) with no other symptoms.
There was no abnormal behavior or conversation before
or during our examination.
On the way back to his home, the patient suddenly for-
got how to get home and which train to take. About 4
hours later, he suddenly knew where he was, and he went
back to his home in the evening without any injury, palsy
or visual or speech disturbances. He had had amnesia for
several hours. After returning to his home and on the fol-
lowing days, his physical and mental status was the same
as usual. However, he did not remember what had hap-
pened to him. There was no witness to his behavior dur-
ing the amnestic period.
After 2 weeks he consulted a neurologist, and the epi-
sode was diagnosed as TGA. The mini-mental state ex-
amination (MMSE) score was 21/30, indicating slight
cognitive impairment. He had never undergone the
MMSE before the event. His families mentioned his
slight forgetfulness for several months. However, no
other abnormal behavior was reported. Brain magnetic
resonance imaging ( MRI ) showed non-specific slight
cerebral atrophy associated with signs of aging (Fig. 1)
Treatment with duloxetine and pregabaline was discon-
tinued, and there was no deterioration of amnesia for at
least 8 months after the episode.
Discussion
The diagnosis of TGA is clinical and one of exclusion.
Differential diagnoses include several other transient am-
nesic disorders with varying epidemiology and disease
courses２）. Transient epileptic amnesia (TEA) is a rare
form of temporal epilepsy, often associated with motor
automatisms of brief duration, occurrence on awakening,
and multiple attacks. Prominent and short durations of
retrograde amnesia occur in patients with TEA. Our pa-
tient did not have a past history of epilepsy, and antero-
grade amnesia began during the daytime, persisted for
about 4 hours, and presented as a single event of disori-
entation to place. Transient ischemic attack (TIA) usually
lasts for less than 1 hour with some other symptoms,
such as palsy, speech disturbances, or perception distur-
bances. Patients with psychogenic amnesia have isolated
retrograde amnesia. Brain MRI with diffusion-weighted
imaging (DWI) can demonstrate even minute and tran-
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sient hippocampal lesions shortly after events in patient
with TGA. In our patient, DWI was not performed during
and shortly after the episode, but TGA was diagnosed on
the basis of the characteristic episodes. He was slightly
feverish on morning of the presentation, but his physical
condition did not exacerbate subsequently. Many events
have been reported to potentially trigger hippocampal
ischemia, including emotional or physical changes, the
Valsalva maneuver, postural changes, medical proce-
dures, and changes in body temperature２）. Fever on the
day of onset might have triggered our patient’s illness.
Pregabarin and duloxetine are popular drugs for the man-
agement of PHN. Opioid analgesics are also recom-
mended for intractable PHN３）. Because our patient had
recurrent exacerbations of pain in association with at-
mospheric temperature changes in the winter season, we
needed to increase the doses of analgesics, which led to
polypharmacy. Drug-drug interactions induced by
polypharmacy are known to cause cognitive disfunction２）.
Some analgesic or hypnotic drugs can also affect cog-
nitive function. Anticholinergic drugs such as tricyclic
antidepressants or benzodiazepines may cause cognitive
disfunction, but serotonin-noradrenaline reuptake inhibi-
tors are not considered to worsen it.
Opioids and pregabalin have effects on the GABAer-
gic receptor system, thereby affecting cognitive func-
tion４）. Pickering et al. reported cognitive impairment and
pain associated with antidepressants in patients with
PHN. Chronic pain itself might also impair cognitive
function５）.
We consider drug-drug interactions the most likely
cause of TGA in our patient.
Conclusion
We must exercise care and carefully administer drugs
that affect cognitive function when treating elderly pa-
tients with chronic pain.
Consent for publication was obtained from the patient.
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